822 related articles for article (PubMed ID: 30819375)
1. Sex-Specific Epidemiology of Heart Failure Risk and Mortality in Europe: Results From the BiomarCaRE Consortium.
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
JACC Heart Fail; 2019 Mar; 7(3):204-213. PubMed ID: 30819375
[TBL] [Abstract][Full Text] [Related]
2. Sex Differences and Similarities in Atrial Fibrillation Epidemiology, Risk Factors, and Mortality in Community Cohorts: Results From the BiomarCaRE Consortium (Biomarker for Cardiovascular Risk Assessment in Europe).
Magnussen C; Niiranen TJ; Ojeda FM; Gianfagna F; Blankenberg S; Njølstad I; Vartiainen E; Sans S; Pasterkamp G; Hughes M; Costanzo S; Donati MB; Jousilahti P; Linneberg A; Palosaari T; de Gaetano G; Bobak M; den Ruijter HM; Mathiesen E; Jørgensen T; Söderberg S; Kuulasmaa K; Zeller T; Iacoviello L; Salomaa V; Schnabel RB;
Circulation; 2017 Oct; 136(17):1588-1597. PubMed ID: 29038167
[TBL] [Abstract][Full Text] [Related]
3. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory markers and incident heart failure in older men: the role of NT-proBNP.
McKechnie DG; Papacosta AO; Lennon LT; Welsh P; Whincup PH; Wannamethee SG
Biomark Med; 2021 Apr; 15(6):413-425. PubMed ID: 33709785
[TBL] [Abstract][Full Text] [Related]
5. Diabetes status-related differences in risk factors and mediators of heart failure in the general population: results from the MORGAM/BiomarCaRE consortium.
Vuori MA; Reinikainen J; Söderberg S; Bergdahl E; Jousilahti P; Tunstall-Pedoe H; Zeller T; Westermann D; Sans S; Linneberg A; Iacoviello L; Costanzo S; Salomaa V; Blankenberg S; Kuulasmaa K; Niiranen TJ
Cardiovasc Diabetol; 2021 Sep; 20(1):195. PubMed ID: 34583686
[TBL] [Abstract][Full Text] [Related]
6. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
Skoglund PH; Arpegård J; Ostergren J; Svensson P
Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
[TBL] [Abstract][Full Text] [Related]
7. Racial differences in the association of NT-proBNP with risk of incident heart failure in REGARDS.
Patel N; Cushman M; Gutiérrez OM; Howard G; Safford MM; Muntner P; Durant RW; Prabhu SD; Arora G; Levitan EB; Arora P
JCI Insight; 2019 Jun; 5(13):. PubMed ID: 31162140
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular biomarkers predict post-discharge re-hospitalization risk and mortality among Swedish heart failure patients.
Molvin J; Jujic A; Bachus E; Gallo W; Tasevska-Dinevska G; Holm H; Melander O; Fedorowski A; Magnusson M
ESC Heart Fail; 2019 Oct; 6(5):992-999. PubMed ID: 31339668
[TBL] [Abstract][Full Text] [Related]
9. Natriuretic and Inflammatory Biomarkers as Risk Predictors of Heart Failure in Middle-Aged Men From the General Population: A 21-Year Follow-Up.
Ergatoudes C; Thunström E; Hansson PO; Morales D; Mandalenakis Z; Rosengren A; Zhong Y; Caidahl K; Fu M
J Card Fail; 2018 Sep; 24(9):594-600. PubMed ID: 30048772
[TBL] [Abstract][Full Text] [Related]
10. Sex and Race Differences in N-Terminal Pro-B-type Natriuretic Peptide Concentration and Absolute Risk of Heart Failure in the Community.
Myhre PL; Claggett B; Yu B; Skali H; Solomon SD; Røsjø H; Omland T; Wiggins KL; Psaty BM; Floyd JS; Selvin E; Ballantyne CM; Shah AM
JAMA Cardiol; 2022 Jun; 7(6):623-631. PubMed ID: 35476049
[TBL] [Abstract][Full Text] [Related]
11. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
[TBL] [Abstract][Full Text] [Related]
12. Relative Importance of History of Heart Failure Hospitalization and N-Terminal Pro-B-Type Natriuretic Peptide Level as Predictors of Outcomes in Patients With Heart Failure and Preserved Ejection Fraction.
Kristensen SL; Jhund PS; Køber L; McKelvie RS; Zile MR; Anand IS; Komajda M; Cleland JGF; Carson PE; McMurray JJV
JACC Heart Fail; 2015 Jun; 3(6):478-486. PubMed ID: 26046842
[TBL] [Abstract][Full Text] [Related]
13. Biomarker-based risk prediction in the community.
AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
[TBL] [Abstract][Full Text] [Related]
14. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
[TBL] [Abstract][Full Text] [Related]
15. Periodontal Status, C-Reactive Protein, NT-proBNP, and Incident Heart Failure: The ARIC Study.
Molinsky RL; Yuzefpolskaya M; Norby FL; Yu B; Shah AM; Pankow JS; Ndumele CE; Lutsey PL; Papapanou PN; Beck JD; Colombo PC; Demmer RT
JACC Heart Fail; 2022 Oct; 10(10):731-741. PubMed ID: 36175058
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
17. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.
Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Mogelvang R
Eur J Heart Fail; 2014 Jun; 16(6):633-8. PubMed ID: 24723498
[TBL] [Abstract][Full Text] [Related]
18. Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure.
de Antonio M; Lupon J; Galan A; Vila J; Urrutia A; Bayes-Genis A
Am Heart J; 2012 May; 163(5):821-8. PubMed ID: 22607860
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, Neurohormonal Correlates, and Prognosis of Heart Failure Stages in the Community.
Xanthakis V; Enserro DM; Larson MG; Wollert KC; Januzzi JL; Levy D; Aragam J; Benjamin EJ; Cheng S; Wang TJ; Mitchell GF; Vasan RS
JACC Heart Fail; 2016 Oct; 4(10):808-815. PubMed ID: 27395350
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
